Latest news with #AstoneaLabs'
Business Standard
6 days ago
- Business
- Business Standard
BSE SME Astonea Labs inches higher on debut
Shares of Astonea Labs was trading at Rs 138.90 on the BSE, a premium of 2.89% compared with the issue price of Rs 135. The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public offer (IPO) price. The stock was currently up 1.05% over its listing price. The counter hit a high of Rs 140 and a low of Rs 136.15. About 5.03 lakh shares of the company changed hands at the counter. Astonea Labs' IPO was subscribed 2.44 times. The issue opened for bidding on 27 May 2025 and it closed on 29 May 2025. The price band of the IPO was set at Rs 128-135 per share. The IPO comprised fresh issue of 20,00,000 shares. The promoter and promoter shareholding diluted to 72.30% from 98.42% pre-IPO. The company intends to utilize the net proceeds for expenses related to product registration in Bolivia (South America), purchase and installation of plant and machinery for export-grade ointment production at its Haryana facility, advertising, marketing and brand building, investment in hardware and software, working capital requirements, and general corporate purposes. Ahead of the IPO, Astonea Labs on 26 May 2025, raised Rs 10.66 crore from anchor investors. The board allotted 7,90,000 shares at Rs 135 per share to 4 anchor investors. Astonea Labs specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynaecological concerns, analgesics, fungal infections, and multivitamins. It also offers products for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums. The company has total 217 employees. The company recorded revenue from operations of Rs 69.55 crore and net profit of Rs 4.10 crore for the period ended 31 December 2024.
Time of India
30-05-2025
- Business
- Time of India
Astonea Labs IPO allotment: Here's how to check status, listing details and what GMP signals
The allotment for Astonea Labs' IPO is expected to be finalised today. Investors who placed bids in the issue between May 27 and May 29 can check their allotment status online through the BSE website or registrar KFin Technologies . Shares are expected to be credited to successful bidders' demat accounts on June 2, with the stock set to list on the BSE SME platform on June 3. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play this game for 1 minute and see why everyone is addicted. Undo The IPO saw a moderate overall subscription of 1.79 times. The retail portion was subscribed 1.69 times, and the non-institutional investor (NII) category showed relatively stronger interest at 5.60 times. However, the Qualified Institutional Buyers (QIB) segment remained underwhelming, with bids covering just 70% of the allocated quota. This uneven demand, especially weak QIB participation, may weigh on listing day sentiment. Adding to the subdued tone is the latest grey market premium (GMP) for Astonea Labs IPO , which stands at zero. This suggests that the stock may list around its issue price of Rs 135 per share, with no significant listing gains expected as of now. Live Events How to Check Astonea Labs IPO Allotment on BSE: Visit: Select 'Equity' and 'Astonea Labs' from the dropdown. Enter your application number or PAN. Click 'Search' to view the allotment status. Check via KFin Technologies (Registrar): Visit: Choose 'Astonea Labs IPO' Enter your PAN, application number, or DP/client ID. Click 'Submit' to view your allotment. Astonea Labs is a contract manufacturer of pharmaceutical and cosmetic products and also markets its own brands like 'Glow Up' and 'Regero'. The company has a presence in both domestic and export markets, including countries like Iraq and Yemen. Proceeds from the IPO will go towards registration expansion in Bolivia, installation of machinery for international-standard ointment production, advertising, tech upgrades, and working capital.
Economic Times
30-05-2025
- Business
- Economic Times
Astonea Labs IPO allotment: Here's how to check status, listing details and what GMP signals
The company has a presence in both domestic and export markets, including countries like Iraq and Yemen. Astonea Labs' IPO allotment is expected to be finalized today, with shares potentially credited to successful bidders by June 2 and listing on June 3. The IPO saw a subscription of 1.79 times, driven by NII interest, but QIB participation was weak. The grey market premium is currently zero, suggesting a listing around the issue price of Rs 135. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads The allotment for Astonea Labs' IPO is expected to be finalised today. Investors who placed bids in the issue between May 27 and May 29 can check their allotment status online through the BSE website or registrar KFin Technologies Shares are expected to be credited to successful bidders' demat accounts on June 2, with the stock set to list on the BSE SME platform on June IPO saw a moderate overall subscription of 1.79 times. The retail portion was subscribed 1.69 times, and the non-institutional investor (NII) category showed relatively stronger interest at 5.60 the Qualified Institutional Buyers (QIB) segment remained underwhelming, with bids covering just 70% of the allocated quota. This uneven demand, especially weak QIB participation, may weigh on listing day to the subdued tone is the latest grey market premium (GMP) for Astonea Labs IPO , which stands at zero. This suggests that the stock may list around its issue price of Rs 135 per share, with no significant listing gains expected as of to Check Astonea Labs IPO Allotment on BSE:Visit: Select 'Equity' and 'Astonea Labs' from the your application number or 'Search' to view the allotment via KFin Technologies (Registrar):Visit: Choose 'Astonea Labs IPO'Enter your PAN, application number, or DP/client 'Submit' to view your Labs is a contract manufacturer of pharmaceutical and cosmetic products and also markets its own brands like 'Glow Up' and 'Regero'.The company has a presence in both domestic and export markets, including countries like Iraq and Yemen. Proceeds from the IPO will go towards registration expansion in Bolivia, installation of machinery for international-standard ointment production, advertising, tech upgrades, and working capital.(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of Economic Times)
